Clyra Medical Technologies is a company within the Medical Technology category. Clyra Medical Technologies is a specialized medical device company that develops advanced wound care solutions based on proprietary oxidative chemistry. Their products are engineered to provide antimicrobial efficacy against a broad spectrum of microorganisms without inducing bacterial resistance or damaging healthy tissue.
Clyra Medical Technologies is rated Emerging on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.
AI narrative accuracy for Clyra Medical Technologies is Moderate. Significant factual deltas detected. Some AI models omit key brand facts.
AI models classify Clyra Medical Technologies as a Phantom. Invisible to AI.
Clyra Medical Technologies appeared in 3 of 8 sampled buyer-intent queries (38%). The brand is likely to appear for highly specific queries regarding 'oxidative wound care' but will struggle to appear in a list of 'top FDA-cleared wound cleansers' due to lower digital authority compared to incumbents.
AI will reliably identify Clyra as a medical technology firm focused on advanced wound care and oxidative antimicrobial solutions. It may struggle with specific business details such as founding date, exact headquarters, and the specific names of all FDA-cleared products due to sparse structured data. Key gap: The gap between its status as a 510(k) cleared medical device company versus a generic 'skin cleanser' brand; AI may fail to distinguish the clinical-grade medical device classification from over-the-counter consumer hygiene products.
Of 5 key facts verified about Clyra Medical Technologies, 2 are well-documented (likely accurate across AI models), 1 have limited sourcing, and 2 are retrieval-dependent and may be inaccurate without live search.
The lack of specific product names (e.g., 'Clyra Sol' vs 'Clyra Gel') on the main landing page makes it difficult for AI to accurately list its commercial catalog.
Buyers turn to Clyra Medical Technologies for Standard Antiseptics: Hospitals and clinics using standard povidone-iodine or chlorhexidine gluconate solutions for wound cleansing., Saline Irrigation: Using sterile saline or tap water to irrigate wounds without specialized antimicrobial agents., Status Quo Protocols: Maintaining existing wound care protocols without integrating advanced copper-iodine technology., among 3 documented problem areas.
Buyers evaluating Clyra Medical Technologies typically ask AI models about "copper iodine wound care technology", "best hospital wound irrigation solutions", "FDA cleared biofilm treatment for chronic wounds", and 1 similar queries.
Clyra Medical Technologies's core products are Antimicrobial wound irrigation, skin cleansers, and super absorbent wound dressings..
Clyra Medical Technologies uses Enterprise/Custom (typically hospital/clinical procurement).
Clyra Medical Technologies serves Hospitals, wound care clinics, dermatologists, and surgical centers..
Clyra Medical Technologies Uses gentle oxidative chemistry that provides broad-spectrum antimicrobial efficacy without the cytotoxicity, staining, or stinging associated with traditional antiseptics.
Brand Authority Index (BAI) tier: Emerging (exact score locked for unclaimed brands)
Archetype: Phantom
https://optimly.ai/brand/clyra
Last analyzed: May 9, 2026
Founded: Not specified on homepage
Headquarters: Not specified on homepage
This profile is part of the Optimly Brand Trust Registry — a verified index of 60,000+ brand profiles that AI models read from when answering buyer-intent questions about brands and categories. Optimly identifies which third-party sources AI cites about each brand, prepares structured brand information for those sources, and measures whether AI representation improves.
If this is your brand, you can claim this profile to verify its contents and correct what AI models say about you: Claim this profile